期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 117, 期 10, 页码 2740-2750出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI31809
关键词
-
资金
- NCI NIH HHS [NCI P50CA75907, P50 CA070907] Funding Source: Medline
Lung cancer is the leading cause of cancer death worldwide. The disease is particularly difficult to detect, and patients often present at an advanced stage. Current treatments have limited effectiveness, and unfortunately, the prognosis remains poor. Recent insights into the molecular pathogenesis and biologic behavior of lung cancer have led to the development of rationally designed methods of early detection, prevention, and treatment of this disease. This article will review the important clinical implications of these advances, with a focus on new molecularly targeted therapies currently in development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据